PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY
Live / Registered — Registered (as of 10 Mar 2020)
What this means for you
Registered since 10 Mar 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87982664
- Registration number
- 6008629
- Mark type
- Design + words
- Filed
- 23 Jun 2017
- Published for opposition
- 14 Nov 2017
- Registered
- 10 Mar 2020
- Attorney of record
- Harold Milstein
Goods and services
- Class 042 — Scientific and technological services: Product development research, product development, and product development consultation regarding pharmaceutical, biological and biotechnological products; Pharmaceutical research and development services; medical research and development services in the field of treatments for cancer, diabetes, and central nervous system, autoimmune, bone, metabolic, and blood disorders
Owner
- Plexxikon Inc., Berkeley, CA, US
- Plexxikon Inc., Berkeley, CA, US
- Plexxikon Inc., Berkeley, CA, US
Prosecution history
- 10 Mar 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 15 Apr 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Apr 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Apr 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 10 Mar 2020 — REGISTERED-PRINCIPAL REGISTER
- 04 Feb 2020 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 04 Feb 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Feb 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Feb 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Jan 2020 — USE AMENDMENT FILED
- 03 Feb 2020 — DIVISIONAL PROCESSING COMPLETE
- 06 Jan 2020 — DIVISIONAL REQUEST RECEIVED
- 03 Feb 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Jan 2020 — TEAS REQUEST TO DIVIDE RECEIVED
- 06 Jan 2020 — TEAS STATEMENT OF USE RECEIVED